Bristol Myers Squibb

From backpacking through the California mountains with a renowned physician-scientist to developing a hypothesis, collecting, analyzing and presenting data, the R&D internship program prioritizes recruiting interns from diverse backgrounds.

The idea of using one drug to treat many diseases is not entirely new. Historically, therapeutics like immunosuppressants or steroids have been used broadly across many immune-mediated diseases.

Bristol Myers Squibb employees will embark on a cross-country bike ride from the coast of Oregon to honor loved ones who have been impacted by cancer by raising money to support the V Foundation for Cancer Research.

Scientists and experts at Bristol Myers Squibb are working to revolutionize the process of drug development with sophisticated scientific strategies driven by technology.

Nearly a decade ago, the first Coast 2 Coast 4 Cancer cycling event began with 53 employees riding 3,000 miles across the U.S. to honor loved ones impacted by cancer by raising funds for cancer research.

As part of the Bristol Myers Squibb Foundation’s $100+ million initiative to increase diversity in clinical trials, Winn CIPP is a six-week immersive summer service-learning experience that aims to train more than 250 diverse clinical investigators.

In his 15 years as a lung cancer specialist, Professor Nicolas Girard, MD, PhD, of the Curie-Montsouris Thorax Institute has seen – and helped advance – dramatic changes in how patients with this disease are treated.